Exact Sciences Rg
EXAS
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
02/28/2026 - 02:00:00
Bid
02/27/2026 - 21:59:59
Bid
Volume
Ask
02/27/2026 - 21:59:59
Ask
Volume
103.38
+0.13 ( +0.13% )
103.36
1,100
103.38
4,400
More information
Analysis by TheScreener
24.02.2026
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 24.02.2026
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 15.08.2025.
Interest
  Strong
Three stars since 24.02.2026.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 24.02.2026 at a price of 103.45.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its dividend-adjusted forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this, the stock traded above its moving average since 05.09.2025.
4wk Rel Perf
  1.53%
 
The four-week dividend-adjusted overperformance versus SP500 is 1.53%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 03.02.2026.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -1.95%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.25%.
Mkt Cap in $bn
  19.75
With a market capitalization >$8bn, EXACT SCIENCES CORPN is considered a large-cap stock.
G/PE Ratio
  1.71
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
  89.47
The estimated PE is for the year 2027.
LT Growth
  153.00%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  10
Over the last seven weeks, an average of 10 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  50
For 1% of index variation, the stock varies on average by 0.50%.
Correlation
  0.15
Stock movements are totally independent of index variations.
Value at Risk
  24.83
The value at risk is estimated at USD 24.83. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  10.10.2012